A ‘Shark Tank’-funded test for food sensitivity is medically dubious, experts say
When Julia Cheek walked onto the set of “Shark Tank,” her five potential investors wore their trademark scowls. Yet within minutes, their demeanor changed, eyebrows raised and heads nodding as they peppered her with questions about her company, EverlyWell, and its promise to revolutionize medical diagnostics.
“EverlyWell is transforming lab testing — a $25 billion market — to be simple, convenient, and useful for you,” she told the judges with a smile. Beside her sat a display of the company’s wares: mail-order test kits for everything from testosterone levels to sexually transmitted infections.
When Cheek left the stage, she had a fresh $1 million commitment from investor Lori Greiner. And the company is wowing more than just the television judges. EverlyWell garnered $6 million
